Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI) : significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-02-01

著者

• KISHIMOTO Tadamitsu

  Osaka University

• MIYASAKA Nobuyuki

  Tokyo Medical and Dental University

• YAMAMOTO Kazuhiko

  The University of Tokyo

• KAWAI Shinichi

  Toho University Omori Medical Center

• TAKEUCHI Tsutomu

  Saitama Medical Center/School

• NISHIMOTO Norihiro

  Laboratory of Immune Regulation, Wakayama Medical University

• Azuma Junichi

  Osaka University

• YAMAMOTO Kazuhiko

  University of Tokyo

• Nishimoto Norihiro

  Laboratory Of Immune Regulation Graduate School Of Frontier Biosciences Osaka University

• Nishimoto Norihiro

  Wakayama Medical University

• Azuma Junichi

  Osaka Pharmaceutical Research Clinic:faculty Of Pharmaceutical Science Osaka University

• Kawai Shinichi

  Toho University

• Nishimoto Norihiro

  Laboratory Of Immune Regulation

関連論文

• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs
• Characteristics of fracture and related factors in patients with rheumatoid arthritis
• Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases
• Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI) : significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition
• OE-081 Activation of STATS protects heart from myocardial injury induced by ischemia/reperfusion(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
• Humanized Anti-Interleukin 6 Receptor Antibody Induced Long-term Remission in a Patient with Life-Threatening Refractory Autoimmune Hemolytic Anemia
• A regulatory role for suppressor of cytokine signaling-1 in T_h polarization in vivo
• -149-EXPRESSION OF INTERLEUKIN 1 IN DCM HEARTS : Cardiomyopathy : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
• Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment : a report of two cases
• Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis : meta-analysis of six initial trials and five long-term extensions
• A case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab
• A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years
• Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab : subanalysis of the SA
• Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease
• Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiograp
• 3B-15 Non-Clinical Studies Performed Before Phase 1 Clinical Trials.
• Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
• Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
• Diagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab : a report of two cases
• Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs-a multicenter, double-blind, parallel-group trial
• Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases
• Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis : the JMAAV study
• A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
• Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents : a retrospective multicenter study in Japan

もっと見る 閉じる

スポンサーリンク